Compass Therapeutics Inc (CMPX)
1.17
-0.03
(-2.50%)
USD |
NASDAQ |
Jun 13, 14:10
Compass Therapeutics Shareholders Equity (Quarterly): 157.06M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 157.06M |
| December 31, 2023 | 148.54M |
| September 30, 2023 | 160.04M |
| June 30, 2023 | 168.29M |
| March 31, 2023 | 175.26M |
| December 31, 2022 | 181.64M |
| September 30, 2022 | 116.12M |
| June 30, 2022 | 126.93M |
| March 31, 2022 | 134.49M |
| Date | Value |
|---|---|
| December 31, 2021 | 140.08M |
| September 30, 2021 | 23.89M |
| June 30, 2021 | 28.88M |
| March 31, 2021 | 33.47M |
| December 31, 2020 | 39.94M |
| September 30, 2020 | 47.29M |
| June 30, 2020 | 53.25M |
| December 31, 2019 | -118.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-118.60M
Minimum
Dec 2019
181.64M
Maximum
Dec 2022
95.09M
Average
126.93M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 161.14M |
| Total Liabilities (Quarterly) | 4.082M |